Resources

New and Emerging Trends in Cancer Treatment: CAR-T

Home | Resources

Nearly 40% of men and women will be diagnosed with cancer at some point in their lives. Treatment innovation in this area is critical to fighting the disease.

In an effort to understand these emerging trends, we asked prescribers to share their thoughts on chimeric antigen receptor T cell therapy, also known as CAR T-cell. In this on-demand webinar, prescribers will provide their perceptions on awareness, knowledge and promise. We review the latest CAR T-cell research finding and examine prescriber sentiments towards autologous and allogeneic CAR-T.

Participants will learn more about:

  • Historical context for CAR T-cell as a therapeutic approach
  • Prescriber perspectives on CAR T-cell awareness, treatment and expectations
  • U.S. hematologists’ and oncologists’ analysis of autologous vs. allogeneic CAR-T

Please fill out the form below to access this content

Related Resources

Building Better Benchmarks

Building Better Benchmarks

What does good look like? If you're a pharma market researcher or marketer, you've probably come to rely on industry benchmarks to judge success and guide your team. But have you ever stopped to think about those benchmarks? How should they be calculated? Are you...

read more
2021 Apollo Healthcare Predictions

2021 Apollo Healthcare Predictions

Every year we ask our physicians their views on the future of the healthcare industry. With so much disruption from COVID-19, this year’s global healthcare predictions will provide a unique window into the minds of those professionals perhaps most tested by 2020 and...

read more
The Impact of COVID-19 on Diabetes Patients

The Impact of COVID-19 on Diabetes Patients

Molly Simpson, InCrowd Director of Client Engagement, and Christine Dworkin, InCrowd Senior Director of Client Services and Head of Tracking, share findings on the Impact of COVID-19 on Diabetes Patients. In this webinar Ms. Simpson will review recent InCrowd data...

read more